Barbara Duncan

Barbara Duncan is a seasoned board member and leader with extensive experience in finance and biotechnology. They served as an associate at Dillon Read from 1994 to 1998, followed by a vice president role at Lehman Brothers until 2001. They have held various board positions at companies such as Edgemont Pharmaceuticals, Intercept Pharmaceuticals, and Fusion Pharmaceuticals, and currently serve as the chairperson at PhoreMost Ltd and a board member at multiple organizations, including Atea Pharmaceuticals and Halozyme. Barbara earned an MBA from The Wharton School and a BS in Accounting from Louisiana State University.